CAN
CTXR icon

Cetera Advisor Networks’s Citius Pharmaceuticals CTXR Stock Holding History

Cetera Advisor Networks’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-600
Closed -$30K – 2052
2021
Q3 		$30K Buy
600
+40
+7% +$2.01K ﹤0.01% 1938
2021
Q2 		$49K Hold
560
– – ﹤0.01% 1872
2021
Q1 		$25K Buy
+560
New +$22.3K ﹤0.01% 1470

Other funds holding CTXR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cetera Advisor Networks's CTXR Position: Q4 2021 in Review

Cetera Advisor Networks sold out of Citius Pharmaceuticals (CTXR) in Q4 2021, closing a stake of 600 shares — an estimated $30K sold.

Cetera Advisor Networks first reported a position in CTXR in Q1 2021 and held it in 3 quarters. The position peaked at $49K in Q2 2021. 76 funds tracked by Wall St. Rank hold CTXR as of Q4 2021.

  • Cetera Advisor Networks reported no remaining Citius Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 600 Citius Pharmaceuticals shares in Q4 2021, an estimated $30K.
  • Cetera Advisor Networks first reported a position in Citius Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Cetera Advisor Networks's Citius Pharmaceuticals position peaked at $49K in Q2 2021.
  • 76 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q4 2021.

Based on Cetera Advisor Networks's 13F filing for Q4 2021, filed 14 Feb 2022.